Skip to main content
Journal cover image

INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction

Publication ,  Journal Article
Zile, MR; Costanzo, MRR; Ippolito, EM; Zhang, Y; Stapleton, R; Sadhu, A; Jimenez, J; Hobbs, J; Sharma, V; Warman, EN; Streeter, L; Butler, J
Published in: ESC Heart Failure
April 2021

Duke Scholars

Published In

ESC Heart Failure

DOI

EISSN

2055-5822

ISSN

2055-5822

Publication Date

April 2021

Volume

8

Issue

2

Start / End Page

849 / 860

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zile, M. R., Costanzo, M. R. R., Ippolito, E. M., Zhang, Y., Stapleton, R., Sadhu, A., … Butler, J. (2021). INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 8(2), 849–860. https://doi.org/10.1002/ehf2.13231
Zile, Michael R., Maria Rosa R. Costanzo, Ekaterina M. Ippolito, Yan Zhang, Russell Stapleton, Ashish Sadhu, Javier Jimenez, et al. “INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction.” ESC Heart Failure 8, no. 2 (April 2021): 849–60. https://doi.org/10.1002/ehf2.13231.
Zile MR, Costanzo MRR, Ippolito EM, Zhang Y, Stapleton R, Sadhu A, et al. INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction. ESC Heart Failure. 2021 Apr;8(2):849–60.
Zile, Michael R., et al. “INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction.” ESC Heart Failure, vol. 8, no. 2, Oxford University Press (OUP), Apr. 2021, pp. 849–60. Crossref, doi:10.1002/ehf2.13231.
Zile MR, Costanzo MRR, Ippolito EM, Zhang Y, Stapleton R, Sadhu A, Jimenez J, Hobbs J, Sharma V, Warman EN, Streeter L, Butler J. INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction. ESC Heart Failure. Oxford University Press (OUP); 2021 Apr;8(2):849–860.
Journal cover image

Published In

ESC Heart Failure

DOI

EISSN

2055-5822

ISSN

2055-5822

Publication Date

April 2021

Volume

8

Issue

2

Start / End Page

849 / 860

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology